Advertisement

Percutaneous Mechanical Circulatory Assistance

  • P. Urban
Conference paper
  • 93 Downloads
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1997)

Abstract

Established cardiogenic shock is a dramatic clinical occurrence, and in-hospital mortality still remains very high, in the region of 80% [1]. It is most often caused by acute myocardial infarction, valvular dysfunction, myocarditis, cardiomyopathy, or by post-cardiotomy pump failure [2]. While cardiac transplantation has a major impact on the acute course of cardiogenic shock in selected cases, and acute revascularization with bypass surgery [3] or balloon angioplasty [4] may have a role to play, pharmacological treatment has generally been disappointing. Thus, although thrombolysis can be effective in preventing the occurrence of shock when it is given early enough in the course of myocardial infarction, it does not influence mortality when the hemodynamics are already profoundly affected [5]. Inotropic and vasodilator agents are nearly always used, but they are generally ineffective to reverse full-blown cardiogenic shock [6].

Keywords

Acute Myocardial Infarction Cardiogenic Shock Circulatory Support Ventricular Septal Rupture Ventricular Assistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goldberg RJ, Gore JM, Alpert JS, et al (1991) Cardiogenic shock after acute myocardial infarction–Incidence and mortality from a community-wide perspective, 1975–1988. N Engl J Med 325: 1117–1122PubMedCrossRefGoogle Scholar
  2. 2.
    Schreiber TL, Miller DH, Zola B (1989) Management of myocardial infarction shock: Current status. Am Heart J 117: 435–442PubMedCrossRefGoogle Scholar
  3. 3.
    De Wood MA, Notske RN, Hensley GR, et al (1980) Intra-aortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 61: 1105–1112CrossRefGoogle Scholar
  4. 4.
    Lee LL, Bates ER, Pitt B, et al (1988) Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 78: 1345–1351PubMedCrossRefGoogle Scholar
  5. 5.
    Gruppo Italiano per to studio delta supravivenza nell’infarcto miocardico, GISSI-2 (1990) A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 336: 65–70Google Scholar
  6. 6.
    Leier CV, Binkley PF (1991) Acute positive inotropic intervention: The catecholamines. Am Heart J 121: 1866–1870PubMedCrossRefGoogle Scholar
  7. 7.
    Pennington DG, McBride LR, Swartz MT, et al (1989) Use of the Pierce-Donachy ventricular assist device in patients with cardiogenic shock after cardiac operations. Ann Thorac Surg 47: 130–135PubMedCrossRefGoogle Scholar
  8. 8.
    Kantrowitz A, Wasfie T, Freed PS, et al (1986) Intra-aortic balloon pumping 1967 through 1982: Analysis of complications in 733 patients. Am J Cardiol 57: 976–983PubMedCrossRefGoogle Scholar
  9. 9.
    Shawl FA, Domanski MJ, Punja S, Hernandez TT (1989) Percutaneous cardiopulmonary bypass support in high risk patients undergoing transluminal coronary angioplasty. Am J Cardiol 64: 1258–1263PubMedCrossRefGoogle Scholar
  10. 10.
    Merhige ME, Smalling RW, Cassidy D, et al (1989) Effect of the hemopump left ventricular assist device on regional myocardial perfusion and function. Circulation 80 (Suppl III): 158–166CrossRefGoogle Scholar
  11. 11.
    Lane AS, Woodward AC, Goldman MR (1987) Massive propranolol overdose poorly responsive to pharmacological therapy: Use of the intra-aortic balloon pump. Ann Emerg Med 16: 1381–1383PubMedCrossRefGoogle Scholar
  12. 12.
    Keogh AM, Billlingham ME, Schroeder JJ (1989) Rapid histological changes in endomyocardial biopsy specimens after myocarditis. Brit Heart J 64: 406–408CrossRefGoogle Scholar
  13. 13.
    Macgovern GJ, Park SB, Macgovern GJ Jr, et al (1987) Mechanical circulatory assist devices. Tex Heart Inst J 14: 276–283Google Scholar
  14. 14.
    Ellis SG, O’Neill WW, Bates ER, et al (1989) Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 13: 1251–1259PubMedCrossRefGoogle Scholar
  15. 15.
    Bolli R (1990) Mechanism of myocardial“stunning”. Circulation 82: 723–773PubMedCrossRefGoogle Scholar
  16. 16.
    Kern MJ (1991) Intra-aortic balloon counterpulsation. Coronary Art Dis 2: 649–660Google Scholar
  17. 17.
    Freed PS, Wasfie T, Zado B, et al (1988) Intra-aortic balloon pumping for prolonged circulatory support. Am J Cardiol 61: 554–557PubMedCrossRefGoogle Scholar
  18. 18.
    Mueller H, Ayeres SM, Conklin EF, et al (1971) The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest 50: 1885–1900PubMedCrossRefGoogle Scholar
  19. 19.
    The American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction) (1992) ACC/AHA guidelines for the early management of patients with acute myocardial infarction. Circulation 82: 664–707Google Scholar
  20. 20.
    Ohman EM, George BS, White CJ, et al (1994) Use of aortic counterpulsation to improve sustained coronary patency during acute myocardial infarction, Circulation 90: 792–799PubMedCrossRefGoogle Scholar
  21. 21.
    Prewitt RM, Go S, Schick U, et al (1994) Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol 23: 794–798PubMedCrossRefGoogle Scholar
  22. 22.
    Vogel RA, Tommaso CL (1990) Elective supported angioplasty: Initial report of the national registry. Cardiac Cath Cardiovasc Diagn 20: 22–26CrossRefGoogle Scholar
  23. 23.
    Rees MR, Browne T, Sivananthan UM, et al (1992) Cardiac resuscitation with percutaneous cardiopulmonary support. Lancet 240: 513–514CrossRefGoogle Scholar
  24. 24.
    Shawl FA, Domanski MJ, Wish MH, et al (1990) Emergency cardiopulmonary bypass support in patients with cardiac arrest in the catheterization laboratory. Cardiac Cath Cardiovasc Diagn 19: 8–12CrossRefGoogle Scholar
  25. 25.
    Pavlides GS, Hauser AM, Stack RK, et al (1991) Effect of peripheral cardiopulmonary bypass on left ventricular size, afterload and myocardial function during elective supported coronary angioplasty. J Am Coll Cardiol 18: 499–505PubMedCrossRefGoogle Scholar
  26. 26.
    Ciardullo RC, Schaff HV, Flaherty JT, et al (1977) Myocardial ischemia during cardiopulmonary bypass. J Thorac Cardiovasc Surg 73: 746–756PubMedGoogle Scholar
  27. 27.
    Loisance D, Dubois-Randé JL, Deleuze PH, et al (1990) Prophylactic intraventricular pumping in high-risk coronary angioplasty. Lancet 335: 438–440PubMedCrossRefGoogle Scholar
  28. 28.
    Wampler RK, Frazier OH, Lansing AM, et al (1991) Treatment of cardiogenic shock with the hemopump left ventricular assist device. Ann Thorac Surg 52: 506–513PubMedCrossRefGoogle Scholar
  29. 29.
    Smalling RW (1991) The hemopump: A transvalvular, axial flow, left ventricular assist device. Coronary Art Dis 2: 667–671Google Scholar
  30. 30.
    Frazier OH, Wampler RK, Duncan JM, et al (1990) First human use of the hemopump, a catheter-mounted ventricular assist device. Ann Thorac Surg 49: 299–304PubMedCrossRefGoogle Scholar
  31. 31.
    Smalling RW, Sweeney M, Lachterman B, et al (1994) Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. J Am Coll Cardiol 23: 637–644PubMedCrossRefGoogle Scholar
  32. 32.
    Lincoff AM, Popma JJ, Bates ER, et al (1990) Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device. Am Heart J 120: 970–972PubMedCrossRefGoogle Scholar
  33. 33.
    Scholz KH, Figulla HR, Schweda F, et al (1994) Mechanical left ventricular unloading during high risk coronary angioplasty: First use of a new percutaneous transvalvular left ventricular assist device. Cardiac Cath Cardiovasc Diagn 31: 61–69CrossRefGoogle Scholar
  34. 34.
    Urban P, Chatelain P, Killisch JP, Morandini E, Verin V, Rutishauser W (1996) Use of a percutaneous transvalvular axial pump for left ventricular assistance during high risk angioplasty. J Am Coll Cardiol 27 (Suppl A): 337A (Abst)Google Scholar
  35. 35.
    Baldwin RT, Duncan JM, Frazier OH, et al (1991) Patent foramen ovale: A because of hypoxemia in patients on left ventricular support. Ann Thorac Surg 52: 865–867PubMedCrossRefGoogle Scholar
  36. 36.
    Urban P (1994) Mechanical percutaneous ventricular assist devices. Anaesth Pharmacol Rev 2: 342–346Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • P. Urban

There are no affiliations available

Personalised recommendations